Pharmaceutical Benefits Division (PBD) – Departmental Records Listing (1 January 2017 - 30 June 2017)

Page last updated: 16 August 2017

PDF version: Pharmaceutical Benefits Division (PBD) – Departmental Records Listing (1 January 2017 - 30 June 2017) (PDF 114 KB)

Record Number
Title
PBD - Pharmaceutical Benefits Division
E17-64330 FINANCIAL MANAGEMENT - Audit - PBS statistics and data - ANAO audit of the Fifth Community Pharmacy Agreement (5CPA)
E17-77221 FINANCIAL MANAGEMENT - Grant funding - Funding Approvals - 2018-19 to 2020-21
E17-70597 GOVERNMENT RELATIONS - Advice - Pharmacy Programs - Briefings - 2017
E17-63239 GRANT MANAGEMENT - Agreements - National Return & Disposal of Unwanted Medicines (NatRUM) - FA - 2015-2018 - Final documents
E17-63903 GRANT MANAGEMENT - Agreements - ******** Funding Agreement - 2015-18 - Final versions
E17-78417 HEALTH BENEFITS - Addresses (presentations) - 68th Session of the Regional Committee for the Western Pacific Region of the World Health Organization
E17-67270 HEALTH BENEFITS - Communication - The Pharmacy Guild of Australia
E17-60712 HEALTH BENEFITS - Policy - Pharmacy Guild of Australia - ******** continuation of service
E17-65354 PHARMACEUTICAL BENEFITS & ACCESS - Advice - Price agreements - 1 Jan 2017 - Excluding PB11a forms
E17-65360 PHARMACEUTICAL BENEFITS & ACCESS - Advice - Price agreements - 2 Feb 2017 - Excluding PB11a forms
E17-66657 PHARMACEUTICAL BENEFITS & ACCESS - Advice - Price agreements - 4 Apr 2017 - Excluding PB11a forms
E17-66702 PHARMACEUTICAL BENEFITS & ACCESS - Advice - Price agreements - 5 May 2017 - Excluding PB11a forms
E17-54962 PHARMACEUTICAL BENEFITS & ACCESS - Advice - Price agreements - 5 May 2017 - Excluding PB11a forms (PH17/13956)
E17-66711 PHARMACEUTICAL BENEFITS & ACCESS - Advice - Price agreements - 6 Jun 2017 - Excluding PB11a forms
E17-56233 PHARMACEUTICAL BENEFITS & ACCESS - Advice - Price agreements - 6 Jun 2017 - Excluding PB11a forms (PH17/13956)
E17-66716 PHARMACEUTICAL BENEFITS & ACCESS - Advice - Price agreements - 7 Jul 2017 - Excluding PB11a forms
E17-60567 PHARMACEUTICAL BENEFITS & ACCESS - Advice - Price agreements - 7 Jul 2017 - Excluding PB11a forms (PH17/13956)
E17-72823 PHARMACEUTICAL BENEFITS & ACCESS - Advice - Price agreements - 8 Aug 2017 - Excluding PB11a forms
E17-87635 PHARMACEUTICAL BENEFITS & ACCESS - Advice - Price agreements - 9 Sep 2017 - Excluding PB11a forms
E17-66994 PHARMACEUTICAL BENEFITS & ACCESS - Advice - Price Disclosure - 2017 April special PBAC meeting - Ratified minutes
E17-84147 PHARMACEUTICAL BENEFITS & ACCESS - Advice - Quality Use of Medicines - Briefs - 2017
E17-66196 PHARMACEUTICAL BENEFITS & ACCESS - Advice - Quality Use of Medicines - Inputs - 2017
E17-65582 PHARMACEUTICAL BENEFITS & ACCESS - Advice - Quality Use of Medicines - Media - 2017
E17-83739 PHARMACEUTICAL BENEFITS & ACCESS - Advice - Quality Use of Medicines - Ministerial submissions - 2017
E17-83710 PHARMACEUTICAL BENEFITS & ACCESS - Advice - Quality Use of Medicines - QNs - Senate Estimates & Parliamentary - 2017
E17-66208 PHARMACEUTICAL BENEFITS & ACCESS - Advice - Quality Use of Medicines - Senate enquiries
E17-65777 PHARMACEUTICAL BENEFITS & ACCESS - Advice - QUM - Grants - Advice from AGS
E17-77214 PHARMACEUTICAL BENEFITS & ACCESS - Agreements - 2017 Continuous Glucose Monitoring (CGM) - Change order with ********
E17-77188 PHARMACEUTICAL BENEFITS & ACCESS - Agreements - 2017 Continuous Glucose Monitoring (CGM) - Supplier agreement with ********
E17-77202 PHARMACEUTICAL BENEFITS & ACCESS - Agreements - 2017 Continuous Glucose Monitoring (CGM) - Supplier agreement with ********
E17-64249 PHARMACEUTICAL BENEFITS & ACCESS - Agreements - Administration Agency - Deed of Agreement
E17-64250 PHARMACEUTICAL BENEFITS & ACCESS - Agreements - Administration Agency - Deed Of Variation
E17-78798 PHARMACEUTICAL BENEFITS & ACCESS - Agreements - Administration agency - Deliverables 2017-2018 - CSO - Annual report - 2017
E17-81932 PHARMACEUTICAL BENEFITS & ACCESS - Agreements - Continuous Glucose Monitoring (CGM) ******** CGM data collection
E17-82009 PHARMACEUTICAL BENEFITS & ACCESS - Agreements - Continuous Glucose Monitoring ********
E17-87480 PHARMACEUTICAL BENEFITS & ACCESS - Agreements - Contract for services in relation to programmes under the Sixth Community Pharmacy Agreement (6CPA) - 2016-17 Contract Management - April 2017
E17-87482 PHARMACEUTICAL BENEFITS & ACCESS - Agreements - Contract for services in relation to programmes under the Sixth Community Pharmacy Agreement (6CPA) - 2016-17 Contract Management - February 2017
E17-87493 PHARMACEUTICAL BENEFITS & ACCESS - Agreements - Contract for services in relation to programmes under the Sixth Community Pharmacy Agreement (6CPA) - 2016-17 Contract Management - January 2017
E17-87481 PHARMACEUTICAL BENEFITS & ACCESS - Agreements - Contract for services in relation to programmes under the Sixth Community Pharmacy Agreement (6CPA) - 2016-17 Contract Management - March 2017
E17-87479 PHARMACEUTICAL BENEFITS & ACCESS - Agreements - Contract for services in relation to programmes under the Sixth Community Pharmacy Agreement (6CPA) - 2016-17 Contract Management - May 2017
E17-70568 PHARMACEUTICAL BENEFITS & ACCESS - Agreements - Contract management distributors - 2017-2020 - ********
E17-84698 PHARMACEUTICAL BENEFITS & ACCESS - Agreements - Contract management distributors - 2017-2020 - Australian Pharmaceutical Industries Ltd (API) DoV 1 - Final
E17-84711 PHARMACEUTICAL BENEFITS & ACCESS - Agreements - Contract management distributors - 2017-2020 - CH2 - DoV 1 - Final
E17-70567 PHARMACEUTICAL BENEFITS & ACCESS - Agreements - Contract management distributors - 2017-2020 - ********
E17-84664 PHARMACEUTICAL BENEFITS & ACCESS - Agreements - Contract management distributors - 2017-2020 - ********
E17-70564 PHARMACEUTICAL BENEFITS & ACCESS - Agreements - Contract management distributors - 2017-2020 - ********
E17-70565 PHARMACEUTICAL BENEFITS & ACCESS - Agreements - Contract management distributors - 2017-2020 - ********
E17-84707 PHARMACEUTICAL BENEFITS & ACCESS - Agreements - Contract management distributors - 2017-2020 - ********
E17-70566 PHARMACEUTICAL BENEFITS & ACCESS - Agreements - Contract management distributors - 2017-2020 - ********
E17-84709 PHARMACEUTICAL BENEFITS & ACCESS - Agreements - Contract management distributors - 2017-2020 - ********
E17-64356 PHARMACEUTICAL BENEFITS & ACCESS - Agreements - CSO distributors - ITA 2017 - Deed of agreement - 1 Jan 2017 to 30 Jun 2018
E17-65027 PHARMACEUTICAL BENEFITS & ACCESS - Agreements - Deed of Agreement with ********
E17-65030 PHARMACEUTICAL BENEFITS & ACCESS - Agreements - Deed of Agreement with ********
E17-65029 PHARMACEUTICAL BENEFITS & ACCESS - Agreements - Deed of Agreement with ********
E17-65026 PHARMACEUTICAL BENEFITS & ACCESS - Agreements - Deed of Agreement with ********
E17-65028 PHARMACEUTICAL BENEFITS & ACCESS - Agreements - Deed of Agreement with ********
E17-65025 PHARMACEUTICAL BENEFITS & ACCESS - Agreements - Deed of Agreement with ********
E17-64664 PHARMACEUTICAL BENEFITS & ACCESS - Agreements - Deliverables - Annual report - 2016
E17-51701 PHARMACEUTICAL BENEFITS & ACCESS - Agreements - Insulin Pump Panel (IP) - Pump Suppliers Panel - Deed of Standing Offers
E17-79324 PHARMACEUTICAL BENEFITS & ACCESS - Agreements - Medical Education and Scientific Advisory Council (MESAC)
E17-74589 PHARMACEUTICAL BENEFITS & ACCESS - Agreements - NDSS Agreement for 2016-2020
E17-73010 PHARMACEUTICAL BENEFITS & ACCESS - Agreements - ********
E17-63011 PHARMACEUTICAL BENEFITS & ACCESS - Agreements - ********
E17-77861 PHARMACEUTICAL BENEFITS & ACCESS - Agreements - Rural & remote access - Agreements with WA & NT 2016 - 2017
E17-62232 PHARMACEUTICAL BENEFITS & ACCESS - Agreements - Strategic Agreement - ********
E17-66948 PHARMACEUTICAL BENEFITS & ACCESS - Benefits listing - PBS Listings -  2017 Schedule of Pharmaceutical Benefits
E17-73604 PHARMACEUTICAL BENEFITS & ACCESS - Benefits listing - PBS listings - Australian Medicines Terminology (AMT)
E17-79790 PHARMACEUTICAL BENEFITS & ACCESS - Committees - 2017 Continuous Glucose Monitoring
E17-79539 PHARMACEUTICAL BENEFITS & ACCESS - Committees - 2017 Continuous Glucose Monitoring - Advisory Group Member TOR
E17-52726 PHARMACEUTICAL BENEFITS & ACCESS - Committees - Agreement Oversight Committee (AOC)
E17-77999 PHARMACEUTICAL BENEFITS & ACCESS - Committees - Biosimilar Awareness Initiative Reference Group - Meeting 5 - 11 Aug 2017
E17-77997 PHARMACEUTICAL BENEFITS & ACCESS - Committees - Biosimilar Awareness Initiative Steering Committee - Meeting 5 - 11 Jul 2017
E17-62976 PHARMACEUTICAL BENEFITS & ACCESS - Committees - Biosimilar Awareness Initiative Steering Committee - Planned Meeting 5 - 30 Mar 2017
E17-79678 PHARMACEUTICAL BENEFITS & ACCESS - Committees - Continuous Glucose Monitoring - Advisory Group Meeting - No 4 - 23 Feb 2017
E17-79733 PHARMACEUTICAL BENEFITS & ACCESS - Committees - Continuous Glucose Monitoring - Advisory Group Meeting - No 5 - 10 May 2017
E17-63483 PHARMACEUTICAL BENEFITS & ACCESS - Committees - COPD draft report - Drug Utilisation Sub Committee (DUSC) & Evaluation Sub Committee (ESC) - June 2017
E17-80724 PHARMACEUTICAL BENEFITS & ACCESS - Committees - COPD final report - PBAC - August 2017
E17-53888 PHARMACEUTICAL BENEFITS & ACCESS - Committees - Drug Utilisation Sub Committee (DUSC) - Meetings - 2017 February
E17-79300 PHARMACEUTICAL BENEFITS & ACCESS - Committees - DUSCPBAC - Public Release Document (PRD) - Diabetes - February 2017
E17-81528 PHARMACEUTICAL BENEFITS & ACCESS - Committees - DUSCPBAC - Public Release Document (PRD) - Everlolimus Tuberous Sclerosis Complex (TSC) - February 2017
E17-76184 PHARMACEUTICAL BENEFITS & ACCESS - Committees - DUSCPBAC - Public Release Document (PRD) - Everolimus breast cancer - February 2017
E17-79632 PHARMACEUTICAL BENEFITS & ACCESS - Committees - DUSCPBAC - Public Release Document (PRD) - Ferric carboxymaltose - February 2017
E17-55703 PHARMACEUTICAL BENEFITS & ACCESS - Committees - DUSCPBAC - Public Release Document (PRD) - Imatinib Gastrointestinal Stromal Tumours (GIST) - February 2017
E17-72668 PHARMACEUTICAL BENEFITS & ACCESS - Committees - Generic Medicines Working Group (GMWG) - June 2017 meeting
E17-63803 PHARMACEUTICAL BENEFITS & ACCESS - Committees - Generic Medicines Working Group (GMWG) - Planning 2017-2018
E17-53193 PHARMACEUTICAL BENEFITS & ACCESS - Committees - Life Saving Drugs Program (LSDP) Disease Advisory Committees
E17-62735 PHARMACEUTICAL BENEFITS & ACCESS - Committees - NDSS agreement 2016-2020 - Medical Education & Scientific Advisory Council (MESAC)
E17-71845 PHARMACEUTICAL BENEFITS & ACCESS - Committees - PBRT - The Pharmacy Guild of Australia
E17-87047 PHARMACEUTICAL BENEFITS & ACCESS - Committees - PMR of biologics - December 2015 - PBAC
E17-87054 PHARMACEUTICAL BENEFITS & ACCESS - Committees - PMR of biologics - Drug Utilisation Subcommittee (DUSC) & Evaluation Sub Committee (ESC) papers
E17-87052 PHARMACEUTICAL BENEFITS & ACCESS - Committees - PMR of biologics - March 2016 PBAC
E17-87821 PHARMACEUTICAL BENEFITS & ACCESS - Committees - PMR of biologics - Ratified minutes
E17-62169 PHARMACEUTICAL BENEFITS & ACCESS - Committees - PMR of biologics for psoriasis - DUSCPBAC - Evaluation Sub Committee (ESC) consideration
E17-50542 PHARMACEUTICAL BENEFITS & ACCESS - Committees - Stoma Appliance Scheme (SAS) - Stoma Product Assessment Panel (SPAP) - 2017 meetings
E17-83953 PHARMACEUTICAL BENEFITS & ACCESS - Committees - Stoma Product Assessment Panel (SPAP) - Application log
E17-69719 PHARMACEUTICAL BENEFITS & ACCESS - Committees - Stoma Product Assessment Panel (SPAP) - April 2017 public summary documents - Coloplast
E17-65523 PHARMACEUTICAL BENEFITS & ACCESS - Committees - Stoma Product Assessment Panel (SPAP) - April 2017 public summary documents - Sutherland Medical
E17-66096 PHARMACEUTICAL BENEFITS & ACCESS - Conferences - 2016 Canberra ARCS Scientific Congress 
E17-72774 PHARMACEUTICAL BENEFITS & ACCESS - Contracting out - Asthma medicines for children 2017 - Final report
E17-72745 PHARMACEUTICAL BENEFITS & ACCESS - Contracting out - Commentary templates for codependent technology - Final report
E17-72759 PHARMACEUTICAL BENEFITS & ACCESS - Contracting out - Multiple Myeloma (MM) medicines utilisation 2017 - Final report
E17-73302 PHARMACEUTICAL BENEFITS & ACCESS - Contracting out - Proton Pump Inhibitors (PPIs) 2017 - PBS data
E17-72764 PHARMACEUTICAL BENEFITS & ACCESS - Contracting out - Proton Pump Inhibitors (PPIs) medicine utilisation 2017 - Final report
E17-50029 PHARMACEUTICAL BENEFITS & ACCESS - Contracting out - Research Project - Proton Pump Inhibitors (PPIs)
E17-53962 PHARMACEUTICAL BENEFITS & ACCESS - Contracting out - Research project - Proton Pump Inhibitors (PPIs)
E17-76368 PHARMACEUTICAL BENEFITS & ACCESS - Data collecting - Approved pharmacy data from DHS 2017
E17-77901 PHARMACEUTICAL BENEFITS & ACCESS - Grants - New Support Programs - Guidelines - 2017
E17-67259 PHARMACEUTICAL BENEFITS & ACCESS - Implementation - Electronic prescribing - AHDA Jurisdictional Advisory Committee
E17-67273 PHARMACEUTICAL BENEFITS & ACCESS - Implementation - Electronic prescribing - AHMAC
E17-67272 PHARMACEUTICAL BENEFITS & ACCESS - Implementation - Electronic prescribing - COAG
E17-67281 PHARMACEUTICAL BENEFITS & ACCESS - Implementation - Electronic prescribing - Department of Human Services DHS
E17-67279 PHARMACEUTICAL BENEFITS & ACCESS - Implementation - Electronic prescribing - DVA
E17-72033 PHARMACEUTICAL BENEFITS & ACCESS - Implementation - Fact and Information Sheets
E17-67380 PHARMACEUTICAL BENEFITS & ACCESS - Implementation - Hospital paperless PBS claiming via Medcharts - Legislation
E17-58793 PHARMACEUTICAL BENEFITS & ACCESS - Implementation - Legislation 2017  Regulations Cost Recovery Orphan Drugs Exemption - PBS Amendments
E17-56054 PHARMACEUTICAL BENEFITS & ACCESS - Implementation - Legislation 2017 BILL- National  Health Budget & Other Legislation Bill 2017
E17-56221 PHARMACEUTICAL BENEFITS & ACCESS - Implementation - Legislation 2017 REGULATIONS Amendments 2017
E17-56048 PHARMACEUTICAL BENEFITS & ACCESS - Implementation - Legislation 2017 Spring BID - Legislation & industry policy
E17-56157 PHARMACEUTICAL BENEFITS & ACCESS - Implementation - Legislation 2017 Sunsetting April - Legislative instruments
E17-57369 PHARMACEUTICAL BENEFITS & ACCESS - Implementation - Legislation 2017 Therapeutic Goods Regulations 1990 Orphan Drugs Amendments
E17-56202 PHARMACEUTICAL BENEFITS & ACCESS - Implementation - Legislation 2018 Sunsetting October - Regulations legislative instruments
E17-76029 PHARMACEUTICAL BENEFITS & ACCESS - Implementation - PBS legislation - Measures tables - Act & regulations
E17-62359 PHARMACEUTICAL BENEFITS & ACCESS - Implementation - Schedule 3 - NDSS existing materials - 2016-2020
E17-62361 PHARMACEUTICAL BENEFITS & ACCESS - Implementation - Schedule 3 - NDSS scheme materials - 2016-2020
E17-88114 PHARMACEUTICAL BENEFITS & ACCESS - Implementation - Schedule 6 - NDSS Access Point (AP) Accreditation - Minutes of approval 2016-2017
E17-88027 PHARMACEUTICAL BENEFITS & ACCESS - Implementation - Schedule 6 - NDSS Access Point (AP) Agreement Extension Letters - Minutes of approval 2016-2017
E17-77066 PHARMACEUTICAL BENEFITS & ACCESS - Liaison - 2016-2017 Continuous Glucose Monitoring (CGM) - Liaison with **********
E17-76381 PHARMACEUTICAL BENEFITS & ACCESS - Liaison - ********** - PB11a - 2017 - Pricing Section
E17-76393 PHARMACEUTICAL BENEFITS & ACCESS - Liaison - ********** - PB11a - 2017 - Pricing Section
E17-76421 PHARMACEUTICAL BENEFITS & ACCESS - Liaison - ********** - PB11a - 2017 - Pricing Section
E17-76424 PHARMACEUTICAL BENEFITS & ACCESS - Liaison - ********** - PB11a - 2017 - Pricing Section
E17-76494 PHARMACEUTICAL BENEFITS & ACCESS - Liaison - ********** - PB11a - 2017 - Pricing Section
E17-72776 PHARMACEUTICAL BENEFITS & ACCESS - Liaison - Asthma medicines for children 2017 - **********
E17-64392 PHARMACEUTICAL BENEFITS & ACCESS - Liaison - Biosimilar Awareness Initiative - External stakeholders - **********
E17-64261 PHARMACEUTICAL BENEFITS & ACCESS - Liaison - Biosimilar Awareness Initiative - External stakeholders - **********
E17-64259 PHARMACEUTICAL BENEFITS & ACCESS - Liaison - Biosimilar Awareness Initiative - External stakeholders - **********
E17-64364 PHARMACEUTICAL BENEFITS & ACCESS - Liaison - Biosimilar Awareness Initiative - External stakeholders - **********
E17-64386 PHARMACEUTICAL BENEFITS & ACCESS - Liaison - Biosimilar Awareness Initiative - External stakeholders - **********
E17-64354 PHARMACEUTICAL BENEFITS & ACCESS - Liaison - Biosimilar Awareness Initiative - External stakeholders - **********
E17-64370 PHARMACEUTICAL BENEFITS & ACCESS - Liaison - Biosimilar Awareness Initiative - External stakeholders - **********
E17-64357 PHARMACEUTICAL BENEFITS & ACCESS - Liaison - Biosimilar Awareness Initiative - External stakeholders - **********
E17-65149 PHARMACEUTICAL BENEFITS & ACCESS - Liaison - Biosimilar Awareness Initiative - External stakeholders - **********
E17-64335 PHARMACEUTICAL BENEFITS & ACCESS - Liaison - Biosimilar Awareness Initiative - External stakeholders - **********
E17-64375 PHARMACEUTICAL BENEFITS & ACCESS - Liaison - Biosimilar Awareness Initiative - External stakeholders - Data discussion meeting
E17-64260 PHARMACEUTICAL BENEFITS & ACCESS - Liaison - Biosimilar Awareness Initiative - External stakeholders - Dissemination of HCP info kits June 2017
E17-75757 PHARMACEUTICAL BENEFITS & ACCESS - Liaison - Biosimilar Awareness Initiative - External stakeholders - Dissemination to Conferences of Health Care Professional  (HCP) information kits
E17-64380 PHARMACEUTICAL BENEFITS & ACCESS - Liaison - Biosimilar Awareness Initiative - External stakeholders - Emails to representative bodies regarding Inflectra listing
E17-64350 PHARMACEUTICAL BENEFITS & ACCESS - Liaison - Biosimilar Awareness Initiative - External stakeholders - **********
E17-64333 PHARMACEUTICAL BENEFITS & ACCESS - Liaison - Biosimilar Awareness Initiative - External stakeholders - **********
E17-64361 PHARMACEUTICAL BENEFITS & ACCESS - Liaison - Biosimilar Awareness Initiative - External stakeholders - **********
E17-64390 PHARMACEUTICAL BENEFITS & ACCESS - Liaison - Biosimilar Awareness Initiative - External stakeholders - **********
E17-64387 PHARMACEUTICAL BENEFITS & ACCESS - Liaison - Biosimilar Awareness Initiative - External stakeholders - **********
E17-64263 PHARMACEUTICAL BENEFITS & ACCESS - Liaison - Biosimilar Awareness Initiative - External stakeholders - November 2016 letter to all stakeholders
E17-64329 PHARMACEUTICAL BENEFITS & ACCESS - Liaison - Biosimilar Awareness Initiative - External stakeholders - **********
E17-64256 PHARMACEUTICAL BENEFITS & ACCESS - Liaison - Biosimilar Awareness Initiative - External stakeholders - Nursing & Midwifery Organisations
E17-64383 PHARMACEUTICAL BENEFITS & ACCESS - Liaison - Biosimilar Awareness Initiative - External stakeholders - Other
E17-64349 PHARMACEUTICAL BENEFITS & ACCESS - Liaison - Biosimilar Awareness Initiative - External stakeholders - **********
E17-64341 PHARMACEUTICAL BENEFITS & ACCESS - Liaison - Biosimilar Awareness Initiative - External stakeholders - **********
E17-64336 PHARMACEUTICAL BENEFITS & ACCESS - Liaison - Biosimilar Awareness Initiative - External stakeholders - **********
E17-64376 PHARMACEUTICAL BENEFITS & ACCESS - Liaison - Biosimilar Awareness Initiative - External stakeholders - **********
E17-64345 PHARMACEUTICAL BENEFITS & ACCESS - Liaison - Biosimilar Awareness Initiative - External stakeholders - **********
E17-64412 PHARMACEUTICAL BENEFITS & ACCESS - Liaison - Biosimilar Awareness Initiative - Internal stakeholders - Generic Medicines Working Group
E17-83274 PHARMACEUTICAL BENEFITS & ACCESS - Liaison - Biosimilar Awareness Initiative - Liaison with **********
E17-80973 PHARMACEUTICAL BENEFITS & ACCESS - Liaison - BiosimilarAwareness Initiative - **********
E17-63458 PHARMACEUTICAL BENEFITS & ACCESS - Liaison - Correspondence external - **********
E17-70373 PHARMACEUTICAL BENEFITS & ACCESS - Liaison - Electronic recording & reporting of controlled drugs (ERRCD) - Jurisdictions
E17-70353 PHARMACEUTICAL BENEFITS & ACCESS - Liaison - ERRCD implementation steering committee - Jurisdictions - ERRCD system modifications
E17-77827 PHARMACEUTICAL BENEFITS & ACCESS - Liaison - ERRCD implementation steering committee - Meeting 5 - 14 Jun 2017
E17-62865 PHARMACEUTICAL BENEFITS & ACCESS - Liaison - Final public consultation on the PMR of Biologics in Psoriasis
E17-76386 PHARMACEUTICAL BENEFITS & ACCESS - Liaison - ********** - PB11a - 2017 - Pricing Section
E17-76525 PHARMACEUTICAL BENEFITS & ACCESS - Liaison - ********** - PB11a - 2017 - Pricing Section
E17-81385 PHARMACEUTICAL BENEFITS & ACCESS - Liaison - Joint Oversight Committee meeting - October 2017
E17-76402 PHARMACEUTICAL BENEFITS & ACCESS - Liaison - ********** - PB11a - 2017 - Pricing Section
E17-75753 PHARMACEUTICAL BENEFITS & ACCESS - Liaison - LSDP - Ministerial briefs & inputs 2016-2017
E17-73821 PHARMACEUTICAL BENEFITS & ACCESS - Liaison - LSDP - ********** - 2016-2017
E17-67353 PHARMACEUTICAL BENEFITS & ACCESS - Liaison - LSDP - ********** - 2016-2017
E17-75276 PHARMACEUTICAL BENEFITS & ACCESS - Liaison - LSDP - ********** - Cerezyme home infusion reports - 2017
E17-75277 PHARMACEUTICAL BENEFITS & ACCESS - Liaison - LSDP - ********** - Fabrazyme home infusion reports - 2017
E17-67333 PHARMACEUTICAL BENEFITS & ACCESS - Liaison - LSDP - ********** - 2016-2017
E17-76007 PHARMACEUTICAL BENEFITS & ACCESS - Liaison - ********** - Correspondence with sponsor - 2017 - Pricing Section
E17-76008 PHARMACEUTICAL BENEFITS & ACCESS - Liaison - ********** - PB11a - 2017- Pricing Section
E17-76285 PHARMACEUTICAL BENEFITS & ACCESS - Liaison - ********** - PB11a - 2017 - Pricing Section
E17-79835 PHARMACEUTICAL BENEFITS & ACCESS - Liaison - ********** - Correspondence with sponsor - 2017 - Pricing Section
E17-75314 PHARMACEUTICAL BENEFITS & ACCESS - Liaison - NDSS correspondence with ********** 2016-2020
E17-75321 PHARMACEUTICAL BENEFITS & ACCESS - Liaison - NDSS correspondence with ********** 2016-2020
E17-75290 PHARMACEUTICAL BENEFITS & ACCESS - Liaison - NDSS Correspondence with ********** 2016-2020
E17-63445 PHARMACEUTICAL BENEFITS & ACCESS - Liaison - PB11a signed - ********** - Pricing Section
E17-76067 PHARMACEUTICAL BENEFITS & ACCESS - Liaison - ********** - Correspondence with sponsor - 2017 - Pricing Section
E17-76055 PHARMACEUTICAL BENEFITS & ACCESS - Liaison - ********** - PB11a - 2017 - Pricing Section
E17-76419 PHARMACEUTICAL BENEFITS & ACCESS - Liaison - ********** - PB11a - 2017 - Pricing Section
E17-61834 PHARMACEUTICAL BENEFITS & ACCESS - Liaison - ******** - Ministerial submission - Final report & publication
E17-76210 PHARMACEUTICAL BENEFITS & ACCESS - Liaison - ******* - PB11a - 2017 - Pricing Section
E17-76211 PHARMACEUTICAL BENEFITS & ACCESS - Liaison - ******* - PB11a - 2017 - Pricing Section
E17-76213 PHARMACEUTICAL BENEFITS & ACCESS - Liaison - ******* - PB11a - 2017 - Pricing Section
E17-76513 PHARMACEUTICAL BENEFITS & ACCESS - Liaison - ******* - PB11a - 2017 - Pricing Section
E17-75873 PHARMACEUTICAL BENEFITS & ACCESS - Liaison - ******* - Correspondence with sponsor - 2017 - Pricing Section
E17-75865 PHARMACEUTICAL BENEFITS & ACCESS - Liaison - ******* - PB11a - 2017 - Pricing Section
E17-76257 PHARMACEUTICAL BENEFITS & ACCESS - Liaison - ******* - PB11a - 2017 - Pricing Section
E17-76261 PHARMACEUTICAL BENEFITS & ACCESS - Liaison - ******* - PB11a - 2017 - Pricing Section
E17-66265 PHARMACEUTICAL BENEFITS & ACCESS - Liaison - ******* - Pricing Section
E17-76237 PHARMACEUTICAL BENEFITS & ACCESS - Liaison - ******* - PB11a - 2017 - Pricing Section
E17-76238 PHARMACEUTICAL BENEFITS & ACCESS - Liaison - ******* - PB11a - 2017 - Pricing Section
E17-63108 PHARMACEUTICAL BENEFITS & ACCESS - Meetings - National Return & Disposal of Unwanted Medicines (NatRUM) - Board meetings - 2017
E17-63770 PHARMACEUTICAL BENEFITS & ACCESS - Meetings - NPS MedicineWise - Board meetings - 2017
E17-87184 PHARMACEUTICAL BENEFITS & ACCESS - Policy - 6CPA Annual Reconciliation Resolution
E17-70599 PHARMACEUTICAL BENEFITS & ACCESS - Policy - Legislative amendments under the National Health Act 1953 - Cessation of 99Y & 90 3C
E17-86030 PHARMACEUTICAL BENEFITS & ACCESS - Policy - PBS Pricing - 2017/18 - Reforms to statutory price reductions
E17-61722 PHARMACEUTICAL BENEFITS & ACCESS - Reporting - Annual Survey results - 2017
E17-79865 PHARMACEUTICAL BENEFITS & ACCESS - Reporting - Diabetes Products Section - Review of Aboriginal Health Practitioners (AHPs) mentoring pilot project - Under the NDSS National Development Program (NDP) for ATSI people - 2016-2017
E17-70249 PHARMACEUTICAL BENEFITS & ACCESS - Reporting - Electronic prescribing - NHIPPC meeting 11 May 2017
E17-63116 PHARMACEUTICAL BENEFITS & ACCESS - Reporting - National Return & Disposal of Unwanted Medicines (NatRUM) - Annual financial reports - 2011-2018
E17-63173 PHARMACEUTICAL BENEFITS & ACCESS - Reporting - National Return & Disposal of Unwanted Medicines (NatRUM) - Bin collection reports - 2011-2018
E17-63127 PHARMACEUTICAL BENEFITS & ACCESS - Reporting - National Return & Disposal of Unwanted Medicines (NatRUM) - Quarterly progress reports - 2011-2018
E17-62883 PHARMACEUTICAL BENEFITS & ACCESS - Reporting - NDSS annual report for 2016-2017
E17-75514 PHARMACEUTICAL BENEFITS & ACCESS - Reporting - NDSS Key Performance Indicators relating to the Access Point expansion plan 2016-17
E17-63512 PHARMACEUTICAL BENEFITS & ACCESS - Reporting - PBSstats - Senate estimates 201705 - May 2017
E17-87410 PHARMACEUTICAL BENEFITS & ACCESS - Reporting - Schedule 13 - NDSS 2016-17 quarter two progress report - Received 6 Feb 2017
E17-62411 PHARMACEUTICAL BENEFITS & ACCESS - Reporting - Schedule 13 - NDSS 2016-2017 quarter three report - Received on 17 May 2017
E17-61813 PHARMACEUTICAL BENEFITS & ACCESS - Reviewing - PMR - ******* - Final report
E17-61798 PHARMACEUTICAL BENEFITS & ACCESS - Reviewing - PMR - ******* - PBAC 2017
E17-62079 PHARMACEUTICAL BENEFITS & ACCESS - Reviewing - Sunsetting of legislative instrument - 2017
E17-62138 PHARMACEUTICAL BENEFITS & ACCESS - Schedule management - NDSS product schedule - 2017
E17-88819 PHARMACEUTICAL BENEFITS & ACCESS - Schedule management - NDSS Product Schedule - Indexation of NDSS Registrant Copayments from 1 January 2017
E17-62805 PHARMACEUTICAL BENEFITS & ACCESS - Schedule management - Registrant Contributions Remittances for 2016 - 2017
E17-64812 PHARMACEUTICAL BENEFITS & ACCESS - Schedule management - Specialised Supply Section - Payments to the Office of Parliamentary Counsel (OPC) - Legislative instruments 2016-2017
E17-64813 PHARMACEUTICAL BENEFITS & ACCESS - Schedule management - Specialised supply Section - Payments to the Office of Parliamentary Counsel (OPC) - Legislative instruments 2017-2018
E17-52491 PHARMACEUTICAL BENEFITS & ACCESS - Schedule management - Stoma Appliance Scheme (SAS) schedule - 2017
E17-62702 PHARMACEUTICAL BENEFITS & ACCESS - Submissions - 1 - January 2017 - Approval of listings on the PBS with nil financial impact
E17-62673 PHARMACEUTICAL BENEFITS & ACCESS - Submissions - 1 - January 2017 - Approval of minor listings on the PBS
E17-62711 PHARMACEUTICAL BENEFITS & ACCESS - Submissions - 10 - October 2017 - Approval of listings on the PBS with nil financial impact
E17-62695 PHARMACEUTICAL BENEFITS & ACCESS - Submissions - 10 - October 2017 - Approval of minor listings on the PBS
E17-62712 PHARMACEUTICAL BENEFITS & ACCESS - Submissions - 11 - November 2017 - Approval of listings on the PBS with nil financial impact
E17-62697 PHARMACEUTICAL BENEFITS & ACCESS - Submissions - 11 - November 2017 - Approval of minor listings on the PBS
E17-62713 PHARMACEUTICAL BENEFITS & ACCESS - Submissions - 12 - December 2017 - Approval of listings on the PBS with nil financial impact
E17-62699 PHARMACEUTICAL BENEFITS & ACCESS - Submissions - 12 - December 2017 - Approval of minor listings on the PBS
E17-62703 PHARMACEUTICAL BENEFITS & ACCESS - Submissions - 2 - February 2017 - Approval of listings on the PBS with nil financial impact
E17-62676 PHARMACEUTICAL BENEFITS & ACCESS - Submissions - 2 - February 2017 - Approval of minor listings on the PBS
E17-62704 PHARMACEUTICAL BENEFITS & ACCESS - Submissions - 3 - March 2017 - Approval of listings on the PBS with nil financial impact - NO LISTINGS DUE TO XML3 UPDATE
E17-62678 PHARMACEUTICAL BENEFITS & ACCESS - Submissions - 3 - March 2017 - Approval of minor listings on the PBS - NO LISTINGS DUE TO XLM3 UPDATE
E17-62705 PHARMACEUTICAL BENEFITS & ACCESS - Submissions - 4 - April 2017 - Approval of listings on the PBS with nil financial impact
E17-62679 PHARMACEUTICAL BENEFITS & ACCESS - Submissions - 4 - April 2017 - Approval of minor listings on the PBS
E17-62706 PHARMACEUTICAL BENEFITS & ACCESS - Submissions - 5 - May 2017 - Approval of listings on the PBS with nil financial impact
E17-62687 PHARMACEUTICAL BENEFITS & ACCESS - Submissions - 5 - May 2017 - Approval of minor listings on the PBS
E17-62707 PHARMACEUTICAL BENEFITS & ACCESS - Submissions - 6 - June 2017 - Approval of listings on the PBS with nil financial impact
E17-62689 PHARMACEUTICAL BENEFITS & ACCESS - Submissions - 6 - June 2017 - Approval of minor listings on the PBS
E17-62708 PHARMACEUTICAL BENEFITS & ACCESS - Submissions - 7 - July 2017 - Approval of listings on the PBS with nil financial impact
E17-62690 PHARMACEUTICAL BENEFITS & ACCESS - Submissions - 7 - July 2017 - Approval of minor listings on the PBS
E17-62709 PHARMACEUTICAL BENEFITS & ACCESS - Submissions - 8 - August 2017 - Approval of listings on the PBS with nil financial impact
E17-62691 PHARMACEUTICAL BENEFITS & ACCESS - Submissions - 8 - August 2017 - Approval of minor listings on the PBS
E17-62710 PHARMACEUTICAL BENEFITS & ACCESS - Submissions - 9 - September 2017 - Approval of listings on the PBS with nil financial impact
E17-62692 PHARMACEUTICAL BENEFITS & ACCESS - Submissions - 9 - September 2017 - Approval of minor listings on the PBS
E17-65111 PHARMACEUTICAL BENEFITS & ACCESS - Submissions - Biosimilar Awareness Initiative - QTB
E17-65110 PHARMACEUTICAL BENEFITS & ACCESS - Submissions - Biosimilar Awareness Initiative - Questions on Notice (QoN)
E17-70197 PHARMACEUTICAL BENEFITS & ACCESS - Submissions - Botulinum Toxin Program - Pharmaceutical Benefits Advisory Committee (PBAC)